SBC Medical Group Holdings (SBC) AI Stock Analysis

• Market Cap: $352.28M
• Dividend Yield: N/A
• Average Volume (3M): 33.78K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.73
• Revenue Growth: N/A
• EPS Growth: -1484.62%
• Country: US
• Employees: 863
• Sector: Financial
• Sector Strength: 79
• Industry: Consulting Services
• EPS (TTM): -0.02
• Shares Outstanding: 103,611,250
• 10 Day Avg. Volume: 19,204
• 30 Day Avg. Volume: 33,778
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): 0.00
• Price to Cash Flow (P/CF): N/A
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

SBC Medical Group Holdings displays strong financial performance with robust margins and low leverage. However, the negative P/E ratio and lack of dividend yield raise concerns about current valuation. Technical indicators show a bearish trend, adding to market uncertainty. The investment in Bitcoin is a notable positive corporate event, suggesting strategic financial innovation and diversification.

SBC Medical Group Holdings Business Overview & Revenue Model

Company Description

SBC Medical Group Holdings Incorporated provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and internationally. The company offers advertising and marketing services; staff management services, such as recruitment and training; booking reservations for franchisee clinic customers; assistance with franchisee employee housing rentals and facility rentals; construction and design of franchisee clinics; medical equipment; and medical consumables procurement. It provides IT software solutions; breast augmentation, liposuction, and rejuvenation treatments, including treatment of wrinkles, acne, scars, cellulite, excess fat, discoloration, and signs of aging; laser skin toning and spot removal; eyes double fold surgery; rhinoplasty; treatment of osmidrosis and hyperhidrosis; hair transplants; gynecological formation treatments; laser hair removal; face line surgeries; cosmetical dental procedures; tattoo removal; lasik eye surgery; lateral canthoplasty; brow lift procedures; androgenetic alopecia treatment; and cheek sagging prevention methods. The company was founded in 2000 and is headquartered in Irvine, California.

How the Company Makes Money

SBC Medical Group Holdings generates revenue primarily through patient services, including consultations, diagnostics, treatments, and other healthcare-related services offered at its facilities. The company also earns income through partnerships with insurance companies, government programs, and direct contracts with employers for healthcare services. Additional revenue streams include ancillary services, such as laboratory tests and imaging services, which support the core medical offerings. Strategic collaborations with pharmaceutical companies and medical technology firms may contribute to the company's earnings by enhancing its service offerings and operational efficiency.

SBC Medical Group Holdings Financial Statement Overview

Summary

SBC faces significant financial challenges with negative equity and poor cash flow. While there are some operational improvements, these financial weaknesses overshadow them, necessitating strategic changes.

Income Statement

The income statement lacks key revenue data, making it difficult to assess overall performance. However, the company shows some improvement in EBIT and EBITDA from the previous year, indicating potential operational efficiency. Net income declined, which suggests challenges in profitability.

Balance Sheet

The balance sheet reveals a concerning negative stockholders' equity, indicating financial instability. High liabilities relative to equity and a negative equity position pose significant risks. The debt-to-equity ratio cannot be calculated due to negative equity, further underscoring financial weaknesses.

Cash Flow

The cash flow statement highlights severe issues, with negative operating and free cash flows, signaling cash management challenges. The significant fluctuation in financing and investing cash flows between periods suggests potential liquidity risks and inconsistent financial strategies.

Breakdown
TTM	Dec 2023	Dec 2022
Income Statement		Total Revenue
170.24M	193.54M	174.16M
	Gross Profit
126.13M	137.30M	114.83M
	EBIT
62.28M	70.66M	20.12M
	EBITDA
64.72M	85.87M	29.64M
	Net Income Common Stockholders
35.93M	39.37M	6.32M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
53.64M	103.02M	53.64M
	Total Assets
0.00	258.81M	225.48M
	Total Debt
0.00	22.87M	16.13M
	Net Debt
0.00	-80.16M	-35.61M
	Total Liabilities
-107.85M	115.00M	117.63M
	Stockholders Equity
107.85M	142.16M	105.25M
Cash Flow		Free Cash Flow
46.15M	39.44M	-24.99M
	Operating Cash Flow
55.78M	50.64M	-47.37K
	Investing Cash Flow
-12.39M	1.82M	-32.65M
	Financing Cash Flow
11.46M	6.14M	-7.98M

SBC Medical Group Holdings Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 3.22
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SBC, the sentiment is Negative. The current price of 3.22 is below the 20-day moving average (MA) of 3.37, below the 50-day MA of 4.12, and below the 200-day MA of 7.76, indicating a bearish trend. The MACD of -0.27 indicates Negative momentum. The RSI at 34.11 is Neutral, neither overbought nor oversold. The STOCH value of 37.73 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SBC.

SBC Medical Group Holdings Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
UHS	74 Outperform	$11.19B	10.21	17.82%	0.46%	10.82%	65.64%
HCA	73 Outperform	$81.16B	14.98	-230.22%	0.81%	8.67%	15.32%
THC	72 Outperform	$12.47B	4.07	110.75%	―	0.57%	440.71%
ACHC	64 Neutral	$2.45B	9.77	8.73%	―	7.69%	―
Sector *	64 Neutral	$13.44B	9.41	9.19%	4.92%	16.30%	-8.66%
SBC	57 Neutral	$352.28M	―	8.36%	―	―	-1484.62%
CYH	52 Neutral	$336.73M	―	39.18%	―	1.16%	-278.41%

SBC Medical Group Holdings Corporate Events

SBC Medical Group Invests 1 Billion Yen in Bitcoin

On February 12, 2025, SBC Medical Group Holdings announced its decision to purchase Bitcoin, with a planned investment of 1 billion yen through Coinbase, Inc. This move is part of SBC Medical’s strategic initiative to strengthen its financial base and support long-term enterprise value through asset diversification. By investing in Bitcoin, the company aims to leverage cryptocurrencies as a hedge against inflation and enhance its financial stability. The decision highlights SBC Medical’s commitment to flexible financial strategies and transparency in operations, aiming to strengthen trust with shareholders and stakeholders.